Joop van Gerven

10PUBLICATIONS
30CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)PharmacogenomicsToxicology (incl. clinical toxicology)BiomechanicsHuman impacts of climate change and human adaptation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 19, 2025
Adverse immunostimulation in early phase clinical trials: Key findings and recommendations based on the investigator's clinical experience.

Juliette A van den Noort, Marella C E van Ruissen, Lisanne C A Smidt

|May 13, 2025
Safety, Pharmacokinetics, and Pharmacodynamics of a 6-h N,N-Dimethyltryptamine (DMT) Infusion in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled Trial.

Katelijne V van der Heijden, Rob G J A Zuiker, Marije E Otto

|Jan 21, 2025
Clinical Pharmacokinetics of N,N-Dimethyltryptamine (DMT): A Systematic Review and Post-hoc Analysis.

K V van der Heijden, M E Otto, J W Schoones

|Jul 09, 2024
The interactive walkway provides fit-for-purpose fall-risk biomarkers in the elderly: Comparison of zolpidem and suvorexant.

Ingrid Koopmans, Daphne Geerse, Lara de Ridder

|Dec 29, 2021
Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer's disease.

Anne Catrien Baakman, Carmen Gavan, Lotte van Doeselaar

|Jul 16, 2020
The impact of the global COVID-19 pandemic on the conduct of clinical trials: Return to normalcy by considering the practical impact of a structured ethical analysis.

Maurits F J M Vissers, Adam F Cohen, Joop M A Van Gerven

Pageof 2

Frequent Collaborators

2 joint publications

Katelijne V van der Heijden

2 joint publications

Marije E Otto

2 joint publications

Adam F Cohen

2 joint publications

Rob Zuiker